The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.

Leila N AtmowihardjoJob R SchippersImke H BartelinkPierre M BetNienke van ReinKeith PurdyDavid CavallaValérie ComberiatiAndrew McElroySue D SnapeHarm Jan BogaardLeo HeunksNicole JuffermansMarcus SchultzPieter R TuinmanLieuwe D J BosJurjan Aman

Published in: Trials (2022)

ClinicalTrials.gov NCT04794088 . Registered on 11 March 2021.

Keyphrases

acute respiratory distress syndrome
coronavirus disease
sars cov
extracorporeal membrane oxygenation
mechanical ventilation
chronic myeloid leukemia
study protocol
clinical trial
high dose
respiratory syndrome coronavirus
phase iii
randomized controlled trial
low dose
intensive care unit